Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

ClinicalTrials.gov ID: NCT01686152

Public ClinicalTrials.gov record NCT01686152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis of the Face or Balding Scalp

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the comparability of the safety and efficacy of Imiquimod Cream, 3.75% and Zyclara (imiquimod) Cream, 3.75% (the reference listed drug) in subjects with actinic keratosis (AK) of the face or balding scalp. It will also be determined whether the efficacy of each of the two active treatments is superior to that of the Vehicle cream.

Study identification

NCT ID
NCT01686152
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
589 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2012 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
Nov 24, 2020

2012 – 2013

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Radiant Research, Inc. Tucson Arizona 85710 —
Encino Research Center Encino California 91436 —
Dermatology Research Associates Los Angeles California 90045 —
Northern California Research Sacramento California 95821 —
Skin Surgery Medical Group, Inc. San Diego California 92117 —
Longmont Clinic, PC Longmont Colorado 80501 —
Visions Clinical Research Boynton Beach Florida 33472 —
Tampa Bay Medical Research Clearwater Florida 33761 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
International Dermatology Research, Inc. Miami Florida 33144 —
Tory Sullivan, M.D., P.A. North Miami Beach Florida 33162 —
Park Avenue Dermatology, PA Orange Park Florida 32073 —
Leavitt Medical Associates of Florida dba Ameriderm Research Ormond Beach Florida 32174 —
Radiant Research, Inc. Pinellas Park Florida 33781 —
MedaPhase, Inc. Newnan Georgia 30263 —
Altman Dermatology Associates Arlington Heights Illinois 60005 —
The Indiana Clinical Trials Center Plainfield Indiana 46168 —
Dermatology Specialists Research LLC Louisville Kentucky 40202 —
Radiant Research, Inc. Cincinnati Ohio 45249 —
Oregon Medical Research Center, PC Portland Oregon 97223 —
Philadelphia Institute of Dermatology Fort Washington Pennsylvania 19034 —
Omega Medical Research Warwick Rhode Island 02886 —
Research Across America Dallas Texas 75234 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01686152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01686152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →